Quadrant Capital Group’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,278	Closed	-$159K	–	2284
2025 Q1	$159K	Buy	+3,278	New	+$159K	0.01%	1394
2024 Q4	–	Sell	-140	Closed	-$6.3K	–	2781
2024 Q3	$6.3K	Buy	+140	New	+$6.3K	﹤0.01%	2267